Generalized Pustular Psoriasis (GPP) Latest Advances

Find the Latest Research About Generalized Pustular Psoriasis (GPP)

Last Updated: 09/19/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1249 publications

Rapid resolution of generalized pustular psoriasis with upadacitinib.

Rapid resolution of generalized pustular psoriasis with upadacitinib.

Journal: JAAD case reports

Published: August 09, 2026

INDIVIDUAL ARTICLE: Generalized Pustular Psoriasis: A Contemporary Review of Diagnosis, Pathophysiology, and IL-36 Pathway-Directed Management.

INDIVIDUAL ARTICLE: Generalized Pustular Psoriasis: A Contemporary Review of Diagnosis, Pathophysiology, and IL-36 Pathway-Directed Management.

Journal: Journal of drugs in dermatology : JDD

Published: August 05, 2026

Deucravacitinib for Generalized Pustular Psoriasis and Comorbid Polymyositis: Dual Efficacy and Favorable Safety.

Deucravacitinib for Generalized Pustular Psoriasis and Comorbid Polymyositis: Dual Efficacy and Favorable Safety.

Journal: American journal of therapeutics

Published: June 29, 2026

Japanese intractable and rare dermatologic diseases: From the official skin-centered nanbyo core to an illustrative mechanism-based framework.

Japanese intractable and rare dermatologic diseases: From the official skin-centered nanbyo core to an illustrative mechanism-based framework.

Journal: Intractable & rare diseases research

Published: June 24, 2026

Psoriasis as a spatial immune ecosystem: insights from single-cell and spatial transcriptomics.

Psoriasis as a spatial immune ecosystem: insights from single-cell and spatial transcriptomics.

Journal: Frontiers in immunology

Published: June 22, 2026

Early Temporal Dissociation Between C-Reactive Protein and Neutrophil Counts After Spesolimab Treatment in Generalized Pustular Psoriasis.

Early Temporal Dissociation Between C-Reactive Protein and Neutrophil Counts After Spesolimab Treatment in Generalized Pustular Psoriasis.

Journal: Acta dermato-venereologica

Published: June 19, 2026

Clinical Practice Recommendations for Non-Dermatologists on the Diagnostic Suspicion of GPP.

Clinical Practice Recommendations for Non-Dermatologists on the Diagnostic Suspicion of GPP.

Journal: Journal of clinical medicine

Published: June 18, 2026

SAPHO syndrome and pustular skin diseases: shared inflammatory circuits, divergent tissue outcomes, and the limits of a spectrum model.

SAPHO syndrome and pustular skin diseases: shared inflammatory circuits, divergent tissue outcomes, and the limits of a spectrum model.

Journal: Frontiers in immunology

Published: June 11, 2026

Spesolimab successfully treated acute generalized exanthematous pustulosis in an IL36RN-postive patient.

Spesolimab successfully treated acute generalized exanthematous pustulosis in an IL36RN-postive patient.

Journal: JAAD case reports

Published: May 25, 2026

From Pustules to Pruritus: A Novel IL36RN Frameshift Variant Reveals a Triple Biologic Paradox and a Th17-To-Th2 Phenotypic Transition.

From Pustules to Pruritus: A Novel IL36RN Frameshift Variant Reveals a Triple Biologic Paradox and a Th17-To-Th2 Phenotypic Transition.

Journal: The Journal of dermatology

Published: May 23, 2026

Efficacy and Safety of Recibokibart, an Interleukin-36 Receptor Antibody, in Generalized Pustular Psoriasis: A Phase 2 Randomized Trial.

Efficacy and Safety of Recibokibart, an Interleukin-36 Receptor Antibody, in Generalized Pustular Psoriasis: A Phase 2 Randomized Trial.

Journal: The British journal of dermatology

Published: May 21, 2026

Treatment Patterns and Pathways of Systemic Drug Therapy in Patients With Plaque, Erythrodermic, and Generalized Pustular Psoriasis: A Retrospective Cohort Study in Japan.

Treatment Patterns and Pathways of Systemic Drug Therapy in Patients With Plaque, Erythrodermic, and Generalized Pustular Psoriasis: A Retrospective Cohort Study in Japan.

Journal: The Journal of dermatology

Published: May 15, 2026

Showing 1-12 of 1,249

Last Updated: 09/19/2026